Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
InterMune |
---|---|
Information provided by: | InterMune |
ClinicalTrials.gov Identifier: | NCT00043303 |
The purpose of this research study is to test the safety and effectiveness of Interferon gamma-1b (IFN-g 1b) injected subcutaneously (under the skin) for the treatment of advanced liver fibrosis and cirrhosis in patients with chronic hepatitis C infections.
IFN-g 1b is not currently approved for the treatment of liver fibrosis.
Condition | Intervention | Phase |
---|---|---|
Liver Fibrosis Cirrhosis |
Drug: interferon gamma-1b |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Multicenter Study of the Safety and Anti-Fibrotic Efficacy of Interferon-Gamma 1b (Actimmune) in Patients With Severe Lever Fibrosis or Compensated Cirrhosis Due to Hepatitis C. |
Enrollment: | 502 |
Study Start Date: | September 2001 |
Study Completion Date: | November 2003 |
This study will evaluate the safety and tolerability of IFN-g 1b in patients with advanced liver fibrosis and cirrhosis due to hepatitis C. This study will also evaluate whether IFN-g 1b is effective in reducing the amount of fibrosis in the liver.
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Study ID Numbers: | GILF-001 |
Study First Received: | August 7, 2002 |
Last Updated: | October 29, 2007 |
ClinicalTrials.gov Identifier: | NCT00043303 |
Health Authority: | United States: Food and Drug Administration |
hepatitis C liver fibrosis liver cirrhosis |
Virus Diseases Hepatitis Liver Diseases Hepatic fibrosis Digestive System Diseases Interferon Type II |
Fibrosis Interferons Hepatitis, Viral, Human Liver Cirrhosis Hepatitis C Interferon-gamma, Recombinant |
Anti-Infective Agents RNA Virus Infections Pathologic Processes Flaviviridae Infections |
Antineoplastic Agents Therapeutic Uses Antiviral Agents Pharmacologic Actions |